BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 36113896)

  • 1. Oral beclomethasone dipropionate is an effective treatment for immune checkpoint inhibitor induced colitis.
    Alexander JL; Ibraheim H; Richards C; Shum B; Pavlidis P; Hunter N; Teare JP; Wotherspoon A; Furness A; Turajlic S; Pickering L; Larkin J; Speight A; Papa S; Powell N
    J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36113896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosal inflammation predicts response to systemic steroids in immune checkpoint inhibitor colitis.
    Mooradian MJ; Wang DY; Coromilas A; Lumish M; Chen T; Giobbie-Hurder A; Johnson DB; Sullivan RJ; Dougan M
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32414860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety Considerations with the Use of Corticosteroids and Biologic Therapies in Mild-to-Moderate Ulcerative Colitis.
    Cross RK
    Inflamm Bowel Dis; 2017 Oct; 23(10):1689-1701. PubMed ID: 28906290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes of patients with corticosteroid refractory immune checkpoint inhibitor-induced enterocolitis treated with infliximab.
    Alexander JL; Ibraheim H; Sheth B; Little J; Khan MS; Richards C; Hunter N; Chauhan D; Ratnakumaran R; McHugh K; Pinato DJ; Nathan P; Choy J; Crusz SM; Furness A; Turajlic S; Pickering L; Larkin J; Teare JP; Papa S; Speight A; Sharma A; Powell N
    J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34233964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A practical guide to the management of distal ulcerative colitis.
    Ardizzone S; Bianchi Porro G
    Drugs; 1998 Apr; 55(4):519-42. PubMed ID: 9561342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beclomethasone dipropionate in microscopic colitis: Results of an exploratory open-label multicentre study (COLCO).
    Corte T; Janssens E; D'Hondt A; Thorrez K; Arts J; Dejaegher K; D'Heygere F; Holvoet A; van Besien B; Harlet L; Peeters H; Moerkercke WV; Baert F
    United European Gastroenterol J; 2019 Nov; 7(9):1183-1188. PubMed ID: 31700631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of Immune Checkpoint Inhibitor-Induced Colitis: A Systematic Review.
    Nakane T; Mitsuyama K; Yamauchi R; Kakuma T; Torimura T
    Kurume Med J; 2023 Jul; 68(2):43-52. PubMed ID: 37100606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beclomethasone dipropionate (3 mg) enemas combined with oral 5-ASA (2.4 g) in the treatment of ulcerative colitis not responsive to oral 5-ASA alone.
    D'Arienzo A; Manguso F; Castiglione GN; Vicinanza G; Scaglione G; Bennato R; Sanges M; Mazzacca G
    Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):254-7. PubMed ID: 9759590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beclomethasone dipropionate inhaler: a review of its pharmacology, therapeutic value and adverse effects. I: Asthma.
    Brogden RN; Pinder RM; Sawyer PR; Speight TM; Avery GS
    Drugs; 1975; 10(3):166-210. PubMed ID: 172309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral budesonide for induction of remission in ulcerative colitis.
    Sherlock ME; MacDonald JK; Griffiths AM; Steinhart AH; Seow CH
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD007698. PubMed ID: 26497719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral beclomethasone dipropionate: a critical review of its use in the management of ulcerative colitis and Crohn's disease.
    Fascì Spurio F; Aratari A; Margagnoni G; Doddato MT; Chiesara F; Papi C
    Curr Clin Pharmacol; 2012 May; 7(2):131-6. PubMed ID: 22432845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five-year review of corticosteroid duration and complications in the management of immune checkpoint inhibitor-related diarrhoea and colitis in advanced melanoma.
    Favara DM; Spain L; Au L; Clark J; Daniels E; Diem S; Chauhan D; Turajlic S; Powell N; Larkin JM; Yousaf N
    ESMO Open; 2020 Jul; 5(4):. PubMed ID: 32641348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A current overview of corticosteroid use in active ulcerative colitis.
    Salice M; Rizzello F; Calabrese C; Calandrini L; Gionchetti P
    Expert Rev Gastroenterol Hepatol; 2019 Jun; 13(6):557-561. PubMed ID: 30947569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COLAR: open-label clinical study of IL-6 blockade with tocilizumab for the treatment of immune checkpoint inhibitor-induced colitis and arthritis.
    Holmstroem RB; Nielsen OH; Jacobsen S; Riis LB; Theile S; Bjerrum JT; Vilmann P; Johansen JS; Boisen MK; Eefsen RHL; Marie Svane I; Nielsen DL; Chen IM
    J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36096534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Efficacy of Beclomethasone Dipropionate in Korean Patients with Ulcerative Colitis.
    Lee YJ; Cheon JH; Kim JH; Yoo S; Lee HJ; Park SJ; Hong SP; Kim TI; Kim WH
    Yonsei Med J; 2017 Jan; 58(1):144-149. PubMed ID: 27873507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
    Feagan BG; Macdonald JK
    Cochrane Database Syst Rev; 2012 Oct; 10():CD000543. PubMed ID: 23076889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral beclomethasone dipropionate as an alternative to systemic steroids in mild to moderate ulcerative colitis not responding to aminosalicylates.
    Papi C; Aratari A; Moretti A; Mangone M; Margagnoni G; Koch M; Capurso L
    Dig Dis Sci; 2010 Jul; 55(7):2002-7. PubMed ID: 19937467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune Checkpoint Inhibitor-associated Diarrhea and Colitis: A Systematic Review and Meta-analysis of Observational Studies.
    Tran AN; Wang M; Hundt M; Chugh R; Ohm J; Grimshaw A; Ciarleglio M; Hung KW; Proctor DD; Price CC; Laine L; Al-Bawardy B
    J Immunother; 2021 Oct; 44(8):325-334. PubMed ID: 34380976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
    Wang Y; Parker CE; Bhanji T; Feagan BG; MacDonald JK
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD000543. PubMed ID: 27101467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.